Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
MRTX | Mirati Therapeutics, Inc. | Chief Executive Officer, Director | $8.92M | Jan 20, 2023 | ||
QURE | uniQure N.V. | Director | $136K | -$11.4K | -7.73% | Jun 19, 2024 |
CGEM | Cullinan Therapeutics, Inc. | Director | May 15, 2024 | |||
ETTX | Entasis Therapeutics Holdings Inc. | Director | Jul 7, 2022 | |||
FUSN | Fusion Pharmaceuticals Inc. | Director | Jun 4, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|